Health Care Access & Coverage

A Prescription for the Future of Drug Pricing

Penn LDI Conference

9:00a.m. – 2:30p.m. ET May 5, 2023 In-Person Event

Jon M. Huntsman Hall, 8th Floor, Robertson Room, 3730 Walnut Street, Philadelphia PA

The cost of drugs is a top concern for policymakers and the public. The urgency of this issue has resulted in a rapidly changing landscape. In the past year, we’ve seen new federal legislation focused on drug pricing, payment innovations by insurers, and disruptions in the consumer market from the private sector. But what will the effects of these changes be? Join Penn LDI as we host a one-day conference to address new and pending policy changes, public and private sector innovations in this complicated market, and what the future holds for drug pricing.

A Prescription for the Future of Drug Pricing

Conference Agenda

9:00–9:30 a.m.

Breakfast/Registration

9:30–10:30 a.m.

Opening Keynote

Mark McClellan, MD, PhD
Robert J. Margolis Professor of Business, Medicine, and Policy, Duke University; Founding Director, Duke-Margolis Center for Health Policy

10:30–11:30 a.m.

Drug Pricing and the Inflation Reduction Act

  • Troyen Brennan, MD, MPH
    Adjunct Professor, Health Policy and Management, Harvard T.H. Chan School of Public Health
  • Stacie Dusetzina, PhD
    Professor, Health Policy, and Ingram Professor, Cancer Research, Vanderbilt University Medical Center
  • James McSpadden, M.Div, MA
    Senior Policy Advisor, AARP Public Policy Institute
  • Meena Seshamani, MD, PhD
    Deputy Administrator and Director, Centers for Medicare & Medicaid Services
  • Moderator: Holly Fernandez Lynch, JD, MBe
    Assistant Professor, Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania; Assistant Professor, Carey Law School, University of Pennsylvania

11:30 a.m.–12:15 p.m.

New Ways to Pay for High-Cost Drugs

  • Rena Conti, PhD
    Dean’s Research Scholar and Associate Professor, Markets, Public Policy and Law, Questrom School of Business, Boston University
  • Nancy Keating, MD, MPH
    Professor, Health Care Policy, Harvard Medical School; Professor, Medicine and Practicing General Internist, Brigham and Women’s Hospital
  • Jeff Marrazzo, MBA, MPA
    Former CEO, SPARK Therapeutics
  • Moderator: Anand Shah, MD
    Operating Advisor, Clayton, Dubilier & Rice

12:15–12:30 p.m.

Break

12:30–1:30 p.m.

Lunch and Spotlight on Pharmacy Benefit Managers

  • Angela Banks, MBA (invited)
    Vice President, Policy, Pharmaceutical Care Management Association
  • Barak Richman, PhD, JD
    Katherine T. Bartlett Professor, Law; Professor, Business Administration, Duke University
  • Moderator: Dan Gorenstein, Executive Editor and Host, Tradeoffs Podcast

1:30–2:30 p.m.

Outlook on Drug Pricing: Access, Affordability and Innovation

Speakers

Mark McClellan, MD, PhD

Mark McClellan is the Robert J. Margolis Professor of Business, Medicine, and Policy at Duke University and the founding Director of the Duke-Margolis Center for Health Policy. Previously, he served as Senior Director for Health Care Policy at the White House and as Director of the Health Care Innovation and Value Initiatives at the Brookings Institution. He holds an MD from the Harvard-MIT Division of Health Sciences and Technology and a PhD in Economics from the Massachusetts Institute of Technology.

Peter Bach, MD

Peter Bach is the Chief Medical Officer of Delfi Diagnostics, a company that develops liquid biopsy tests for early cancer detection. Previously, he served as Senior Advisor for the U.S. Centers for Medicare and Medicaid Services. He is an expert in health policy and payment who is concerned with expanding access to high-quality and affordable cancer care. He holds an MD from the University of Minnesota and an MPP from the University of Chicago.

Angela Banks

Angela Banks, MBA

Angela Banks is the Vice President of Policy for the Pharmaceutical Care Management Association, which is the national association representing America’s pharmacy benefit managers. Previously, she was the Vice President of External Affairs for UnitedHealth Group, where she was responsible for leading a strategic approach to prescription drug and pharmacy care services policy. She specializes in health policy, patient advocacy, and market access, and she holds both an MBA and an MA in Government from Johns Hopkins University.

Troyen Brennan

Troyen Brennan, MD, MPH

Troyen Brennan is an Adjunct Professor of Health Policy and Management at Harvard University, where he formerly served as Professor of Medicine and Professor of Public Health. Dr. Brennan also aided in the development of CVS Health’s clinical and medical affairs and health care strategy, MinuteClinic, and Accordant Health Care businesses. His recent work focuses on insurers, exploring both government and private policies and their relationship to utilization and spending. He holds an MD and a JD from Yale University.

Sheila Burke

Sheila Burke, RN, MPA

Sheila Burke is the Chair of Baker Donelson’s Government Relations and Public Policy Group and an Adjunct Lecturer of Public Policy at Harvard University. Previously she served as Chief of Staff to former Senate Majority Leader Bob Dole, Deputy Staff Director of the Senate Committee on Finance, and a member of the Medicare Payment Advisory Commission. She holds a BS in nursing from the University of San Francisco and an MPA from the Kennedy School.

Rena Conti, PhD

Rena Conti is an Associate Professor in the Questrom School of Business and an Associate Research Director of Biopharma and Public Policy at Boston University. Her research covers the financing, organization, and regulation of medical care, specifically of prescription drugs used to treat “specialty” conditions. She regularly advises members of the U.S. House of Representatives on the prescription drug market. She holds a PhD in Health Policy with a concentration in Economics from Harvard University.

Stacie Dusetzina

Stacie Dusetzina, PhD

Stacie Dusetzina is a Professor of Health Policy and an Ingram Professor of Cancer Research at the Vanderbilt University School of Medicine. Her research focuses on the ways in which high-priced drugs impact patient access to care. Notably, she is co-author of “Making Medicines Affordable”, a report by the National Academies of Sciences, Engineering and Medicine, and serves on the Medicare Payment Advisory Commission. She holds a PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill.

Adaeze Enekwech, PhD, MPP

Adaeze Enekwech is an Operating Partner at Welsh, Carson, Anderson & Stowe, an investment firm that partners with high-value healthcare companies. Her prior experience includes work with the Congressional Budget Office, the Medicare Payment Advisory Commission, and the White House Office of Management and Budget. In these positions, she has pushed for a transition to value-based care that appropriately serves vulnerable populations. She holds a PhD in Health Services and Policy from the University of Iowa and an MPP from American University.

Dan Gorenstein

Dan Gorenstein

Dan Gorenstein is the Founder and Executive Editor of Tradeoffs, a podcast created to inform policymakers and the public about issues related to the American health care system. Tradeoffs is supported, in part, by the Leonard Davis Institute of Health Economics, of which Mr. Gorenstein is an Adjunct Senior Fellow. Previously, he worked at Marketplace as a senior health care reporter. He holds a BA in Human Development and Social Relations from Earlham College.

Nancy Keating

Nancy Keating, MD, MPH

Nancy Keating is an Associate Physician and a Professor of Health Care Policy and Medicine at Harvard University. Her research examines provider, patient, and health system factors that influence the delivery of high-quality care for individuals with cancer, recently focusing on the effects of the Center for Medicare and Medicaid Services’ Oncology Care Model. She holds an MD from the University of Chicago Pritzker School of Medicine and an MPH from the Harvard School of Public Health.

Holly Fernandez Lynch, JD, MBe

Holly Fernandez Lynch is the John Russell Dickson Presidential Assistant Professor of Medical Ethics at the University of Pennsylvania, an Assistant Professor at the University of Pennsylvania Carey Law School, and a Senior Fellow for the Leonard Davis Institute of Health Economics. In 2018, she founded the Consortium to Advance Effective Research Ethics Oversight, which she co-chairs. Her work focuses on pharmaceutical policy and access, research ethics, and the ethics of gatekeeping in health care. She holds both a JD and an MBe from the University of Pennsylvania.

Jeff Marrazzo, MBA, MPA

Jeff Marrazzo is the Co-Founder and Former CEO of SPARK Therapeutics, the world’s first fully integrated, commercial gene therapy company. During his time with SPARK, he spearheaded the development of novel reimbursement models for genetic medicines. He was also formerly an advisor on financing and delivery of health care to then-Governor Edward Rendell. He holds an MBA from the Wharton School of the University of Pennsylvania and an MPA from Harvard University.

James McSpadden, M.Div, MA

James McSpadden is a Senior Policy Advisor at AARP, where he focuses on prescription drug policy, pricing, access, utilization, and coverage, specifically as they impact older Americans. Before taking on this role, he was involved in the company’s advocacy efforts as a Senior Legislative Representative. He also formerly directed the Home First program at Seabury Resources for Aging, a nonprofit serving older adults in Washington D.C. He holds an MA in Theology from Princeton Theological Seminary and an MDiv from Duke University.

John O'Brien

John O’Brien, PharmD, MPH

John O’Brien is the President and CEO of the National Pharmaceutical Council, a research organization dedicated to examining the clinical and economic value of pharmaceutical innovation. Dr. O’Brien has worked with the Department of Health and Human Services, CareFirst BlueCross BlueShield, and the Centers for Medicare and Medicaid Services, as well as in various academic appointments. He holds a PharmD from Nova Southeastern University and an MPH from Johns Hopkins University.

Barak Richman, PhD, JD

Barak Richman is the Katharine T. Bartlett Professor of Law and Business Administration at Duke University. His areas of research include health law, competition and regulation policy, and institutional economics. Notably, he is co-editor of a symposium volume of Law and Contemporary Problems entitled “Who Pays? Who Benefits? Distributional Issues in Health Care.” He holds a PhD in Business Administration from the University of California, Berkeley and a JD from Harvard University.

James Robinson

James Robinson, PhD, MPH

James Robinson is the Leonard D. Schaeffer Endowed Chair of Health Economics and Policy at the University of California, Berkeley, and the Director of the Berkeley Center for Health Technology, which supports projects examining coverage, management, and payment methods for innovative technologies including biopharmaceuticals, medical devices, and diagnostics. He holds both a PhD in Economics and an MPH in Health Planning and Policy from the University of California, Berkeley.

Meena Seshamani

Meena Seshamani, MD, PhD

Meena Seshamani is the Deputy Administrator and Director of the Centers for Medicare and Medicaid Services. Previously, she served as the Vice President of Clinical Care Transformation at MedStar Health, a not-for-profit health system, where she helped to build new care models and partnerships with regulators and payers. Her work has focused on value-based care initiatives, delivery system reform, and coverage policy. She holds an MD from the University of Pennsylvania and a PhD in Health Economics from the University of Oxford.

Anand Shah

Anand Shah, MD

Anand Shah is an Operating Advisor at Clayton, Dubilier & Rice, and an Adjunct Senior Fellow for the Leonard Davis Institute of Health Economics. He has previously worked with both the U.S. Food and Drug Administration, as well as the Centers for Medicare and Medicaid Services, where he led the clinical design of novel service-delivery and payment models. He holds an MD from the University of Pennsylvania and an MPH in Health Care Management and Policy from Harvard University.